About 1 result found for searched term "LQZ-7I" (0.14 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M20839 | LQZ-7I | Survivin |
| LQZ-7I is a novel selectively inhibitor of survivin dimerization with IC50s of 4.8 µM and 3.1 µM in prostate cancer cell lines PC-3 and C4-2, respectively. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
